Join the Fight Against MDS
Every gift helps patients, caregivers, and healthcare professionals access life-saving resources, support, and education. Together, we can make a difference. Even a small contribution can create a big impact. Thank you for your generosity.
Our Podcast
MDS Patient & Family Report
This new initiative of the MDS Foundation is devoted to patients, family members, and other non-professional interested people. In each episode, experts in the field will discuss novel information on MDS, such as new diagnostic techniques, new therapies etc. They will also answer frequently asked questions, which are relevant to many people.
![Allogeneic Stem Cell Transplant for MDS: Advanced Considerations (Part II) [MDS Patient & Family Report]](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_160/images.spreaker.com/original/3e2ee2cf18d85ac46782f6c6a5047d8f.jpg)
January 6, 2026
4. Allogeneic Stem Cell Transplant for MDS: Advanced Considerations (Part II) [MDS Patient & Family Report]
In this follow-up episode, Dr. Nikolaos Papadantonakis continues the conversation with Dr. Colin Vale from Winship Cancer Institute of Emory University and Dr. Nancy Luna Torres from Moffitt Cancer Center, diving deeper into advanced transplant topics. This episode is ideal for patients and families who want to understand the nuances of transplant care and post-transplant management.
January 6, 2026
3. Allogeneic Stem Cell Transplant for MDS: Understanding the Basics (Part I) [MDS Patient & Family Report]
Join host Dr. Nikolaos Papadantonakis as he welcomes Dr. Colin Vale from Winship Cancer Institute of Emory University and Dr. Nancy Luna Torres from Moffitt Cancer Center to discuss the fundamentals of allogeneic hematopoietic stem cell transplantation for MDS patients. Our experts break down complex medical concepts into easy-to-understand language, helping patients make informed decisions about this important treatment option.
September 26, 2025
2. EHA 2025 updates [MDS Patient & Family Report]
This episode features Dr. Nikolaos Papadantonakis from the Winship Cancer Institute of Emory University and Dr. Amer Zeidan from the Yale School of Medicine, discussing research on Myelodysplastic Syndromes (MDS) presented at the 2025 European Hematology Association (EHA) Congress in Milan.
February 25, 2025
1. ASH 2024: MDS in Focus [MDS Patient & Family Report]
Join Dr. Madanat (UT Southwestern, Texas), Dr. Stahl (Harvard Medical School, Massachusetts), and Dr. Papadantonakis (Emory University, Georgia) as they break down key Myelodysplastic Syndromes (MDS) abstracts from the 2024 American Society of Hematology (ASH) meeting.
Tune in to gain valuable insights and stay informed about the evolving landscape of MDS management.
Our Supporters
Thank you to Taiho Oncology for supporting this initiative.
